UBT251 Injection Phase II Clinical Study (CKD)

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of UBT251 injection in obese/overweight chronic kidney disease (CKD) population
Epistemonikos ID: af537404f3f31fc1e11755c0b3cc628de36bb01a
First added on: Aug 22, 2025